Explora is a young and dynamic biotech company focusing on the development of innovative technologies and product to challenge XXI century Science. Presently, Explora prosecutes two business models:
Explora offers to its customers fixed price services with no royalties or other success sharing schemes. Services are provided on a non-exclusive basis.
Contract research programs are carried out on exclusive basis in view of R&D funding, licensing and success payments, developmental milestones, and royalties on end products.
Explora also offers the transfer of its proprietary technologies to its clients in view of technology access fees, up-front and license payments.